(LEGN) – Analyst Comments
-
BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
-
Cantor Fitzgerald Starts Legend Biotech Corp. (LEGN) at Overweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LEGN Stock Lookup